WellPoint

This weekend in Barron's online: the drama over a buyout for Dell, beneficial share buybacks, outraged Russian investors, and the prospects for Eaton, STMicroelectronics and Ruby Tuesday. Cover Story "Michael Dell's Folly" by Andrew Bary. Now that Blackstone Group (NYSE: BX) and activist...

The focus was on the big banks last week, with Goldman Sachs (NYSE: GS), J.P. Morgan (NYSE: JPM) and Morgan Stanley (NYSE: MS) reporting strong results, but Bank of America (NYSE: BAC) and Citigroup (NYSE: C) not so much. The spotlight is on tech earnings this week. Analysts anticipate lower per-...

Express Scripts (NASDAQ: ESRX), which resumed its relationship with Walgreen (NYSE: WAG) in September, is scheduled to report its third-quarter 2012 results Monday, November fifth, after the closing bell. Among other things, investors will be looking to see how the company's acquisition of Medco...

The earnings crunch rolls on. Analysts are looking for strong earnings growth in this week's quarterly reports from Apple, Caterpillar, Starbucks and Visa. But ConocoPhillips, Ford and Netflix are among those expected to post significantly lower per-share earnings, compared to the same period of a...

The earnings crunch is in full swing this this week. Quarterly results are due from the likes of Caterpillar (NYSE: CAT), Exxon Mobil (NYSE: XOM), Procter & Gamble (NYSE: PG) and United Parcel Service (NYSE: UPS), from which analysts expect to see year-over-year earnings growth, as well as...

iShares Dow Jones US Healthcare Provider (NYSE: IHF) is up more than 19% year to date. The fund invests at least 90% of its assets in securities of the underlying index, which measures the performance of the health care providers sector of the U.S. equity market. Top holdings include UnitedHealth...

Wedbush is out with its report today on WellPoint (NYSE: WLP), raising its PT from $80 to $83. In a note to clients, Wedbush writes, "Our new price target of $83, which represents 11x our new estimate of $7.55, reflects a better earnings outlook. We believe multi-line managed care plans will see a...

Citi is out with its report today on WellPoint (NYSE: WLP), maintaining Buy. In a note to clients, Citi writes, "We rate the shares WellPoint Buy / Low Risk. WellPoint guidance assumes that medical cost trends returned to normal on April 1, while the inpatient admissions survey data from our...

Morgan Stanley has modified its earnings per share forecast for WellPoint (NYSE: WLP) upwards. In today's research report, Morgan Stanley stressed that “We are raising our WLP EPS forecasts for 2011/ 2012/2013 by 7-8%, from $6.60/$7.40/$8.20 to $7.10/ $7.90/$8.75.” Morgan Stanley also stressed...

Deutsche Bank is out with its report today on WellPoint (NYSE: WLP), reaffirming Buy. In a note to clients, Deutsche Bank writes, "WLP boosted its 2011 EPS guidance to 'at least $6.60' excluding net investment gains of $0.10, up 5% from the prior view of 'at least $6.30'. We reaffirm our BUY...